Assessment of long-term clinical and functional changes in patients recovering from severe COVID-19-associated lung damage

The problem of long COVID-19 (COronaVIrus Disease 2019) has been highly relevant for the healthcare system in the last three years. The persistence of respiratory symptoms, radiological and functional changes in COVID-19 patients brings new challenges to the entire medical community. The aim of the study is to explore long-term clinical and functional changes in patients with severe COVID-19-associated lung injury, including assessment of functional and radiological abnormalities of the respiratory system, as well as persistent clinical symptoms a year after the acute phase of the disease. Methods. The study included 45 patients who were examined 3, 6 and 12 months after COVID-19 with severe lung damage (more than 50% according to chest CT in the acute phase of the disease). Patients underwent multispiral computed tomography of the chest organs, a comprehensive study of respiratory function (spirography, body plethysmography and diffusion test); the clinical symptoms were assessed. Results. Chest CT scans showed gradual regression of pathological changes during the follow-up. However, radiographic changes of varying severity persisted after 12 months of follow-up in 51% of patients. A year later, restrictive disorders persisted in 20% of patients and the diffusion capacity of the lungs was reduced in 69% of patients. At the same time, a statistically significant difference in the DL_СО level was observed between 3, 6 and 12 months. The severity of dyspnea decreased 1 year after hospitalization in 48% of patients. Conclusion. The obtained results demonstrate a gradual regression of both radiological and functional pathological changes during the 1st year. However, CT changes and deviations of the respiratory function persist in some patients, mainly in the form of a decrease in DL_СО, which necessitates further monitoring of this group of patients.

1. World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at: https://apps.who.int/iris/handle/10665/345824

2. Peghin M., Palese A., Venturini M. et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect. 2021; 27 (10): 1507–1513. DOI: 10.1016/j.cmi.2021.05.033.

3. Mandal S., Barnett J., Brill S.E. et al. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021; 76 (4): 396–398. DOI: 10.1136/thoraxjnl-2020-215818.

4. Shah W., Hillman T., Playford E.D, Hishmeh L. Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021; 372: n136. DOI: 10.1136/bmj.n136.

5. Lehmann A., Gysan M., Bernitzky D. et al. Comparison of pulmonary function test, diffusion capacity, blood gas analysis and CT scan in patients with and without persistent respiratory symptoms following COVID-19. BMC Pulm. Med. 2022; 22: 196. DOI: 10.1186/s12890-022-01987-z.

6. Zhao Y.M., Shang Y.M., Song W.B. et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463. DOI: 10.1016/j.eclinm.2020.100463.

7. Chernyak A.V., Karchevskaya N.A., Savushkina O.I. et al. [Functional changes in the respiratory system after COVID-19-associated lung injury]. Pul'monologiya. 2022; 32 (4): 558–567. DOI: 10.18093/0869-0189-2022-32-4-558-567 (in Russian).

8. Ministry of Health of the Russian Federation [The Temporary Guidelines: Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)]. Version 6 (April 28, 2020). Available at: https://static-1.rosminzdrav.ru/system/attachments/attaches/000/050/116/original/28042020_%D0%9CR_COVID-19_v6.pdf (in Russian).

9. Russian Respiratory Society. [Guidelines. Spirometry]. 2023. Available at: https://www.spulmo.ru/upload/kr/Spirometria_2023.pdf?t=1 (in Russian).

10. Graham B.L., Steenbruggen I., Miller M.R. et al. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am. J. Respir. Crit. Care Med. 2019; 200 (8): e70–88. DOI: 10.1164/rccm.201908-1590st.

11. Wanger J., Clausen J.L., Coates A. et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26 (3): 511–522. DOI: 10.1183/09031936.05.00035005.

12. Graham B.L., Brusasco V., Burgos F. et al. 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur. Respir. J. 2017; 49 (1): 1600016. DOI: 10.1183/13993003.00016-2016.

13. Aisanov Z.R., Kalmanova E.N., Kameneva M. Yu. et al. [Recommendations of the Russian Respiratory Society on scientific research of the treatment system during the COVID-19 pandemic]. Version 1.1 (May 19, 2020). Available at: https://atmosphere-ph.ru/modules/Magazines/articles//pulmo/pp_1_2020_104.pdf (in Russian).

14. ERS. Welcome to the Global Lung Function Initiative calculators for Spirometry, TLCO and Lung volume. Available at: http://gli-calculator.ersnet.org/index.html

15. Zayrat'yants O.V., ed. [Pathological Anatomy of COVID-19: Atlas]. Moscow: DZM; 2020. Available at: https://mosgorzdrav.ru/uploads/imperavi/ru-RU/patanatomiya_covid19_fullv2_compressed.pdf (in Russian).

16. Samsonova M.V., Chernyaev A.L., Omarova Z.R. et al. [Features of pathological anatomy of lungs at COVID-19]. Pul'monologiya. 2020; 30 (5): 519–532. DOI: 10.18093/0869-0189-2020-30-5-519-532 (in Russian).

17. Konopka K.E., Nguyen T., Jentzen J.M. et al. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 infection is morphologically indistinguishable from other causes of DAD. Histopathology. 2020; 77 (4): 570–578. DOI: 10.1111/his.14180.

18. Yao X.H., Li T.Y., He Z.C. et al. [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020; 49 (5): 411–417. DOI: 10.3760/cma.j.cn112151-20200312-00193 (in Chinese).

19. Lopes A.J., Litrento P.F., Provenzano B.C. et al. Small airway dysfunction on impulse oscillometry and pathological signs on lung ultrasound are frequent in post-COVID-19 patients with persistent respiratory symptoms. PLoS One. 2021; 16 (11): e0260679. DOI: 10.1371/journal.pone.0260679.

20. Scaramuzzo G., Ronzoni L., Campo G. et al. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study. BMC Pulm. Med. 2022; 22: 408. DOI: 10.1186/s12890-022-02214-5.

21. Huang L., Yao Q., Gu X. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021; 398 (10302): 747–758. DOI: 10.1016/S0140-6736(21)01755-4.

22. Wu X., Liu X., Zhou Y. et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir. Med. 2021; 9 (7): 747–754. DOI: 10.1016/S2213-2600(21)00174-0.

23. Zhang P., Li J., Liu H. et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020; 8: 8. DOI: 10.1038/s41413-020-0084-5.

24. Liu Y.X., Ye Y.P., Zhang P. et al. [Changes in pulmonary function in SARS patients during the three-year convalescent period]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007; 19 (9): 536–538. DOI: 10.3760/cma.j.issn.1003-0603.2009.09.008 (in Chinese).

25. Tarraso J., Safont B., Carbonell-Asins J.A. et al. Lung function and radiological findings 1 year after COVID-19: a prospective follow-up. Respir. Res. 2022; 23 (1): 242. DOI: 10.1186/s12931-022-02166-8.

26. Stewart I., Jacob J., George P.M. et al. Residual lung abnormalities following COVID-19 hospitalization: interim analysis of the UKILD Post-COVID study. Am. J. Respir. Crit. Care Med. 2023; 207 (6): 693–703. DOI: 10.1164/rccm.202203-0564OC.